SCHEMBL5553506

SCHEMBL5553506

CNOc1ccc2ccccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.58
CYP1A2 P05177 1/20 0.58
AGXT P21549 2/20 0.47
TDP1 Q9NUW8 4/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 1/20 0.45
ALOX5 P09917 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
GAA P10253 1/20 0.42
RCE1 Q9Y256 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PTPN7 P35236 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4968963 0.81 CYP2A6 (0.56) CYP2A6CYP1A2AGXTTDP1KDM4E
SCHEMBL25462520 0.80 CYP1A2 (0.56) CYP2A6CYP1A2TDP1KDM4ECA9
SCHEMBL25462532 0.79 CYP2A6 (0.48) CYP2A6CYP1A2RAB9AMAPTHTT
SCHEMBL25462508 0.78 CYP2A6 (0.46) CYP2A6CYP1A2RAB9AMAPTHTT
SCHEMBL9525075 0.77 CYP2A6 (0.52) CYP2A6CYP1A2AGXTTDP1KDM4E
SCHEMBL5553606 0.75 ALDH1A1 (0.61) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL3500443 0.75 CYP2A6 (0.67) CYP2A6CYP1A2AGXTTDP1KDM4E
SCHEMBL22299079 0.74 CYP2A6 (0.67) CYP2A6CYP1A2AGXTTDP1KDM4E
SCHEMBL11512456 0.74 CA1 (0.39) TDP1KDM4EMAPK1CA1CA2
SCHEMBL6650090 0.74 ALDH1A1 (0.50) CYP2A6CYP1A2AGXTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100460415-C Ketolactones, their use and process for their preparation and pharmaceutical compositions containing them ABBOTT LAB (US) 2009-02-11 CN disclosed
CN-100441591-C Ketolactones, their use and process for their preparation and pharmaceutical compositions containing them ABBOTT LAB (US) 2008-12-10 CN disclosed
US-RE39591-E1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2007-04-24 US disclosed
CN-1273475-C 6-0-substituted ketolides with antibacterial activity ABBOTT CO (US) 2006-09-06 CN disclosed
CN-1680419-A Ketolactones, their use and process for their preparation and pharmaceutical compositions containing them ABBOTT LAB (US) 2005-10-12 CN disclosed
CN-1680418-A Ketolactones, their use and process for their preparation and pharmaceutical compositions containing them ABBOTT LAB (US) 2005-10-12 CN disclosed
CN-1680420-A Ketolactones, their use and process for their preparation and pharmaceutical compositions containing them ABBOTT LAB (US) 2005-10-12 CN disclosed
CN-1237183-A 6-0-substituted ketolides with antibacterial activity ABBOTT CO (US) 1999-12-01 CN disclosed